DekaBank Deutsche Girozentrale Has $22.14 Million Stake in Kenvue Inc. (NYSE:KVUE)

DekaBank Deutsche Girozentrale trimmed its position in shares of Kenvue Inc. (NYSE:KVUE) by 35.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,056,602 shares of the company’s stock after selling 586,867 shares during the period. DekaBank Deutsche Girozentrale owned approximately 0.06% of Kenvue worth $22,142,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Beaumont Financial Advisors LLC boosted its stake in shares of Kenvue by 3.0% in the 4th quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock valued at $377,000 after purchasing an additional 509 shares in the last quarter. Pinnacle Bancorp Inc. boosted its position in Kenvue by 51.3% during the 4th quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock worth $33,000 after buying an additional 526 shares during the period. Manchester Capital Management LLC raised its holdings in Kenvue by 80.8% during the 1st quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock worth $25,000 after purchasing an additional 530 shares during the last quarter. Tradition Wealth Management LLC grew its stake in Kenvue by 2.8% in the fourth quarter. Tradition Wealth Management LLC now owns 21,278 shares of the company’s stock valued at $458,000 after acquiring an additional 575 shares during the period. Finally, MV Capital Management Inc. lifted its holdings in Kenvue by 71.2% during the first quarter. MV Capital Management Inc. now owns 1,544 shares of the company’s stock worth $33,000 after acquiring an additional 642 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on KVUE shares. HSBC boosted their target price on Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Wednesday, May 8th. Deutsche Bank Aktiengesellschaft dropped their price target on Kenvue from $24.00 to $23.00 and set a “buy” rating for the company in a research report on Thursday, July 25th. Citigroup dropped their price target on Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a research report on Wednesday, July 10th. JPMorgan Chase & Co. dropped their price target on Kenvue from $23.00 to $22.00 and set an “overweight” rating for the company in a research report on Monday, July 22nd. Finally, Sanford C. Bernstein initiated coverage on Kenvue in a research report on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price target for the company. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Kenvue presently has an average rating of “Hold” and a consensus price target of $22.45.

Kenvue Trading Up 1.0 %

Shares of Kenvue stock traded up $0.19 on Friday, hitting $18.82. 17,688,715 shares of the company traded hands, compared to its average volume of 16,514,614. The stock’s 50 day moving average price is $18.49 and its 200-day moving average price is $19.44. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.43. The company has a market cap of $36.04 billion, a PE ratio of 24.13, a PEG ratio of 2.07 and a beta of 1.38.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.03. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $3.79 billion. The company’s quarterly revenue was down 24.9% compared to the same quarter last year. Equities research analysts predict that Kenvue Inc. will post 1.13 EPS for the current year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 28th. Investors of record on Wednesday, August 14th will be paid a $0.205 dividend. This is an increase from Kenvue’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Wednesday, August 14th. This represents a $0.82 dividend on an annualized basis and a yield of 4.36%. Kenvue’s payout ratio is 102.56%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.